Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 27;10(2):e0192321.
doi: 10.1128/spectrum.01923-21. Epub 2022 Mar 2.

Neisseria meningitidis Serogroup C Clonal Complex 10217 Outbreak in West Kpendjal Prefecture, Togo 2019

Affiliations

Neisseria meningitidis Serogroup C Clonal Complex 10217 Outbreak in West Kpendjal Prefecture, Togo 2019

Alicia R Feagins et al. Microbiol Spectr. .

Abstract

Togo has reported seasonal meningitis outbreaks caused by non-Neisseria meningitidis serogroup A (NmA) pathogens since the introduction of meningococcal serogroup A conjugate vaccine (MACV, MenAfriVac) in 2014. From 2016 to 2017, NmW caused several outbreaks. In early 2019, a NmC outbreak was detected in the Savanes region of Togo and its investigation is described here. Under case-based surveillance, epidemiological and clinical data, and cerebrospinal fluid specimens were collected for every suspected case of meningitis. Specimens were tested for meningitis pathogens using confirmatory microbiological and molecular methods. During epidemic weeks 9 to 15, 199 cases were reported, with 179 specimens being available for testing and 174 specimens (97.2%) were tested by at least one confirmatory method. The NmC was the predominant pathogen confirmed (93.9%), belonging to sequence type (ST)-9367 of clonal complex (CC) 10217. All NmC cases were localized to the West Kpendjal district of the Savanes region with attack rates ranging from 4.1 to 18.8 per 100,000 population and case fatality rates ranging up to 2.2% during weeks 9 to 15. Of the 93 NmC confirmed cases, 63.4% were males and 88.2% were in the 5 to 29 age group. This is the first report of a NmC meningitis outbreak in Togo. The changing epidemiology of bacterial meningitis in the meningitis belt post-MACV highlights the importance of monitoring of emerging strain and country preparedness for outbreaks in the region. IMPORTANCE The recent emergence of an invasive NmC strain in Togo is an example of the changing bacterial meningitis epidemiology in the meningitis belt post-MACV. The current epidemiology includes the regional circulation of various non-NmA serogroups, which emphasizes the need for effective molecular surveillance, laboratory diagnosis, and a multivalent vaccine that is effective against all serogroups in circulation.

Keywords: Neisseria meningitidis; NmC; Togo; meningitis; outbreak.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIG 1
FIG 1
Epidemiologic curve of 2019 meningitis outbreak in the West Kpendjal district of Togo.
FIG 2
FIG 2
Phylogenetic analysis of the Neisseria meningitidis serogroup C outbreak strains collected from Togo and other meningitis belt countries between 2013 and 2019.

References

    1. GBD 2016 Meningitis Collaborators. 2018. Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:1061–1082. doi:10.1016/S1474-4422(18)30387-9. - DOI - PMC - PubMed
    1. Greenwood B. 1999. Manson lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg 93:341–353. doi:10.1016/s0035-9203(99)90106-2. - DOI - PubMed
    1. Lapeyssonnie L. 1963. Cerebrospinal meningitis in Africa. Bull World Health Organ 28 Suppl:1–114. - PMC - PubMed
    1. Fernandez K, Lingani C, Aderinola OM, Goumbi K, Bicaba B, Edea ZA, Glele C, Sarkodie B, Tamekloe A, Ngomba A, Djingarey M, Bwaka A, Perea W, Ronveaux O. 2019. Meningococcal meningitis outbreaks in the African meningitis belt after meningococcal serogroup a conjugate vaccine introduction, 2011–2017. J Infect Dis 220:S225–S232. doi:10.1093/infdis/jiz355. - DOI - PMC - PubMed
    1. Trotter CL, Lingani C, Fernandez K, Cooper LV, Bita A, Tevi-Benissan C, Ronveaux O, Preziosi MP, Stuart JM. 2017. Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data. Lancet Infect Dis 17:867–872. doi:10.1016/S1473-3099(17)30301-8. - DOI - PubMed

Publication types

LinkOut - more resources